Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CPHICPHI
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CHINA PHARMA HLDGS INC

Yes. Citadel Advisors holds 125,445 shares of CPHI (China Pharma), worth $82,806, as of its Q2 2026 13F filing. It increased the position from 12,924 shares in Q1 2026. Citadel Advisors has held CPHI since Q1 2026, across 2 quarterly 13F filings.

Current Value

$82,806

Current Shares

125,445

Total Value Change

+$41,511

Total Shares Change

+102,375

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
125,445
+870.6%
$82,8060.0%$0.66
24
2026-Q1
New
12,924
-
$7,8840.0%$0.61
25
2025-Q4
Exited
0
-100.0%
$00.0%$1.21
0
2025-Q3
Increased
30,426
+31.9%
$59,3310.0%$1.95
18
2025-Q2
New
23,070
-
$41,2950.0%$1.79
31

Other major holders of CPHI: UBS Group AG, HRT FINANCIAL LP, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used